These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 5584706

  • 1. [Preparation and effect of heterologous anti-dog lymphocyte serums].
    Pichlmayr R.
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(2):161-226. PubMed ID: 5584706
    [No Abstract] [Full Text] [Related]

  • 2. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].
    Pichlmayr R, Brendel W, Pichlmayr I.
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):313-9. PubMed ID: 4969335
    [No Abstract] [Full Text] [Related]

  • 3. Preparation of specific, potent antilymphocyte serum in the horse using dog thymocytes.
    Braf ZF, Smellie WA, Williams GM, Hume DM.
    Surg Forum; 1967; 18():227-9. PubMed ID: 4866923
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Blod picture changes following administration of a heterologous dog antilymphocytic serum].
    Pichlmayr R, Brendel W, Wonigeit K.
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):305-12. PubMed ID: 5591891
    [No Abstract] [Full Text] [Related]

  • 7. Antilymphocyte serum: summary and further observations.
    Woodruff MF.
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract] [Full Text] [Related]

  • 8. [The immunosuppressive agents. VI. Immunosuppressive action of anti-lymphocyte serums].
    Renoux M, Mikol C.
    Presse Med (1893); 1967 Oct 21; 75(43):2167-70. PubMed ID: 6053126
    [No Abstract] [Full Text] [Related]

  • 9. Production and effect of heterologous anti-canine lymphocyte serum.
    Pichlmayr R, Brendel W, Zenker R.
    Surgery; 1967 May 21; 61(5):774-83. PubMed ID: 5337424
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preparation of an effective heterologous anti-lymphocyte serum for use in the dog.
    Atai M, Kelly WD.
    Surg Forum; 1966 May 21; 17():249-51. PubMed ID: 5331815
    [No Abstract] [Full Text] [Related]

  • 12. Prolongation of canine renal allograft survival with antilymphoid antisera.
    Shanfield I, Ladaga LG, Wren SF, Blennerhassett JB, MacLean LD.
    Surg Gynecol Obstet; 1968 Jul 21; 127(1):29-40. PubMed ID: 4872534
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF.
    Transplantation; 1967 Jul 21; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract] [Full Text] [Related]

  • 18. Anti-lymphocyte serum in prolongation of dog renal homografts.
    Lwason RK, Ellis LR, Hodges CV.
    Surg Forum; 1966 Jul 21; 17():515-6. PubMed ID: 5331836
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response.
    Monaco AP, Wood ML, Gray JG, Russell PS.
    J Immunol; 1966 Feb 21; 96(2):229-38. PubMed ID: 5327056
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.